NNC126-0083

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NNC126-0083, covering 2017-02-08 to 2017-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx® [Phase 1]

See pricing